<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>Seven arterial thrombotic events have been reported in patients receiving thalidomide with 3 cases occurring in patients with other predisposing conditions </plain></SENT>
<SENT sid="2" pm="."><plain>We report 4 additional cases of arterial thromboses in 1 <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and 3 <z:mp ids='MP_0009440'>myeloma</z:mp> patients treated with thalidomide </plain></SENT>
<SENT sid="3" pm="."><plain>The mechanism for these events is unclear; however, it is significant that 2 patients were receiving concomitant anticoagulation with aspirin and <z:chebi fb="8" ids="10033">warfarin</z:chebi> </plain></SENT>
</text></document>